Ito, Kyoko
Yokoyama, Keitaro
Nakayama, Masaaki
Fukagawa, Masafumi
Hirakata, Hideki
Article History
Received: 10 May 2021
Accepted: 25 October 2021
First Online: 10 November 2021
Declarations
:
: The protocol was reviewed and approved by an independent ethics committee and the Institutional Review Board of The Jikei University School of Medicine. All participants provided written informed consent before starting the study.
: Not applicable.
: K.I. is an employee of Torii; K.Y. received consulting fees from Torii, Japan Tobacco Inc. and Kyowa Kirin Co., Ltd.; M.N. received consulting fees from Torii; M.F. received consulting fees from Torii, Japan Tobacco Inc. and Bayer Yakuhin Ltd., and research grant and consulting fees from Kyowa Kirin Co., Ltd. and Chugai Pharmaceutical Co., Ltd.; and H.H. received consulting fees from Torii and Japan Tobacco Inc.